Shilpa Medicare Ltd
Karthikeyan Rajakumar has extensive experience in supply chain management, currently serving as Vice President of Supply Chain at Shilpa Medicare Ltd since April 2022, where responsibilities include heading API Strategic Procurement. Previously, Karthikeyan held the position of Vice President - SCM at Swiss Garnier from March 2021 to April 2022, overseeing end-to-end supply chain operations. Prior experience includes serving as Associate Vice President at Hetero Drugs Ltd, focusing on procurement for APIs and formulations, and General Manager roles at both Pfizer and Shasun Pharma Solutions, with a notable background in global sourcing and supply chain management at Orchid Pharma. Karthikeyan's educational background includes schooling at Govt Higher Secondary School Chromepet and Govt School Chromepet.
This person is not in any offices
Shilpa Medicare Ltd
Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The Company's segments include Bulk Drug/Intermediates and Energy. It offers 3a 7b Dihydroxy. The Company deals with APIs, Intermediates, Formulations, New Drug Delivery Systems, Peptides/Biotech products and Specialty Chemicals. The Company supplies oncology/non-oncology APIs and intermediates. Its oncology API products include Anastrozole, Axitinib, Azacitidine, Abiraterone Acetate, Bicalutamide, Bortezomib, Busulphan, Cabazitaxel Amorphous, Capecitabine, Carboplatin, Cladribine, Clofarabine, Zoledronic acid, Vismodegib, Pemetrexed DiPotassium Nonahydrate, Cyclophosphamide Monohydrate and Cytarabine. It also offers AntiRetroVirals. Its non-oncology API products include Acebrophylline, Echothiophate, Nifedipine, Perfenidone, PrucaloprideSuccinate, Sildenafil Citrate, Ursodeoxycholic acid and Dimethyl Fumarate.